Roger Royster to Myocardial Infarction
This is a "connection" page, showing publications Roger Royster has written about Myocardial Infarction.
Connection Strength
0.112
-
Zvara DA, Groban L, Rogers AT, Prielipp RC, Murphy B, Hines M, Hammon JW, Kon ND, Royster RL. Prophylactic nitroglycerin did not reduce myocardial ischemia during accelerated recovery management of coronary artery bypass graft surgery patients. J Cardiothorac Vasc Anesth. 2000 Oct; 14(5):571-5.
Score: 0.036
-
Zvara DA, Galaska HJ, Castellano VP, Vinten-Johansen J, Royster RL, Williams MW, Murphy BA, Kim EJ. Cloricromene reduces myocardial infarct size in rabbits when administered during the early reperfusion period. Anesth Analg. 1997 Feb; 84(2):266-70.
Score: 0.028
-
Zaloga GP, Prielipp RC, Butterworth JF, Royster RL. Pharmacologic cardiovascular support. Crit Care Clin. 1993 Apr; 9(2):335-62.
Score: 0.022
-
Butterworth JF, Bean VE, Royster RL. Sufentanil is preferable to etomidate during rapid-sequence anesthesia induction for aortocoronary bypass surgery. J Cardiothorac Anesth. 1989 Aug; 3(4):396-400.
Score: 0.017
-
Butterworth J, Legault C, Stump DA, Coker L, Hammon JW, Troost BT, Royster RL, Prough DS. A randomized, blinded trial of the antioxidant pegorgotein: no reduction in neuropsychological deficits, inotropic drug support, or myocardial ischemia after coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 1999 Dec; 13(6):690-4.
Score: 0.009